Marker Therapeutics

$2.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.30 (-11.58%) As of 6:53 PM UTC today

Why Robinhood?

You can buy or sell MRKR and other stocks, options, and ETFs commission-free!

About MRKR

Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX. The listed name for MRKR is Marker Therapeutics, Inc. Common Stock.

CEO
Peter L. Hoang
Employees
28
Headquarters
Houston, Texas
Founded
1991
Market Cap
106.46M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
337.55K
High Today
$2.57
Low Today
$2.10
Open Price
$2.53
Volume
447.20K
52 Week High
$3.77
52 Week Low
$1.32

MRKR Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

XONE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure